Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Mitchell
Article
Looking Ahead: 2020 Workers’ Compensation Predictions
The new decade has arrived and we are taking a look ahead at the regulatory and compliance trends we expect to hit the workers’ compensation market
Workers' Comp
Article
The Future of Pain Therapy in Workers’ Compensation
As we move into a new decade, we continue to look for solutions to address the opioid crisis and discover alternative ways to treat pain.
Workers' Comp
Blog
What's the difference between a drug allergy and a side effect?
Drug allergies and side effects present differences that are often misunderstood.
Workers' Comp
White Paper
Disaster Recovery and Work Comp
Careful planning can blunt nature’s impact on workers’ compensationIn just the past few years, natural disasters have generated startling
Mitchell
News Release
Mitchell’s Tina Greene Elected to Cooperative Exchange, The National Clearinghouse Association Board
Mitchell Regulatory and Industry Relations Director Tina Greene was elected to serve on the
Workers' Comp
Blog